Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ)
CNY 8.73
(-0.8%)
CNY 8.73
(-0.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 151.14 Million | 323.04 Million | 136.39 Million | 132.99 Million | 186.46 Million | 199.08 Million |
| Net Income | 120.71 Million | 213.04 Million | 66.1 Million | -684.47 Million | 125.86 Million | 153.31 Million |
| Depreciation & Amortization | 94.41 Million | 91.32 Million | 87.12 Million | 86.07 Million | 81.69 Million | 80.5 Million |
| Deferred income taxes | -11.58 Million | -5.6 Million | -10.14 Million | -1.37 Million | -7.93 Million | -5.45 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -147.05 Million | 11.08 Million | -62.89 Million | 52.11 Million | -51.24 Million | -41.4 Million |
| Other non-cash items | 798.54 Thousand | 7.59 Million | 46.06 Million | 679.27 Million | 30.14 Million | 6.66 Million |
| Investing Cash Flow | -140.5 Million | -61.16 Million | -265.61 Million | -28.87 Million | -138.8 Million | 25.93 Million |
| Investments in PPE | -66.09 Million | -54.14 Million | -85.36 Million | -35.07 Million | -27.2 Million | -26.75 Million |
| Acquisitions | 3.15 Million | -69.16 Million | -201 Million | 35.1 Million | -86.55 Million | 27.57 Million |
| Investment purchases | -110.82 Million | -32.97 Million | -51.85 Million | -126.9 Million | -77.61 Million | -242.83 Million |
| Sales/Maturities of investments | 33.26 Million | 25.24 Million | 72.46 Million | 133.07 Million | 52.32 Million | 294.7 Million |
| Other Investing Activities | -74.4 Million | 69.86 Million | 148.27 Thousand | -35.07 Million | 235.73 Thousand | -26.75 Million |
| Financing Cash Flow | 98.57 Million | -61.85 Million | -46.6 Million | -28.58 Million | -52.27 Million | -74.85 Million |
| Debt repayment | -100.6 Million | -5 Million | -46 Million | -8 Million | -17 Million | -58 Million |
| Dividends payments | -741.08 Thousand | -113.06 Thousand | -325.34 Thousand | -27.57 Million | -32.13 Million | -26.85 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.29 Million | -56.74 Million | -282.46 Thousand | 10 Million | 1.46 Million | 10 Million |
| Accounts receivables | 88.62 Million | -109.54 Million | -220.68 Million | 190.15 Million | 17.98 Million | -7.36 Million |
| Accounts payables | -183.03 Million | 106.13 Million | 198.3 Million | -93.02 Million | -71.3 Million | 12.99 Million |
| Inventory | -41.05 Million | 20.09 Million | -30.37 Million | -43.63 Million | 10.01 Million | -41.57 Million |
| Other working capital | -194.62 Million | -5.6 Million | -10.14 Million | -1.37 Million | -7.93 Million | 176.8 Thousand |
| Cash at beginning of period | 436.22 Million | 234.72 Million | 410.75 Million | 335.64 Million | 340.31 Million | 190.3 Million |
| Cash at end of period | 545.89 Million | 436.22 Million | 234.72 Million | 410.75 Million | 335.64 Million | 340.31 Million |
| Capital Expenditure | -66.09 Million | -54.14 Million | -85.36 Million | -35.07 Million | -27.2 Million | -26.75 Million |
| Effect of forex changes on cash | 459.34 Thousand | 1.47 Million | -213.52 Thousand | -416.57 Thousand | -61.19 Thousand | -162.14 Thousand |
| Net cash flow / Change in cash | 109.67 Million | 201.5 Million | -176.03 Million | 75.11 Million | -4.66 Million | 150 Million |
| Free Cash Flow | 85.04 Million | 268.89 Million | 51.03 Million | 97.91 Million | 159.26 Million | 172.32 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | -50.61 Million | 89.81 Million | 120.71 Million | -12.58 Million | -16.94 Million |
| Depreciation & Amortization | - | 27.64 Million | 27.64 Million | 94.41 Million | 94.41 Million | -46.88 Million |
| Deferred income taxes | - | - | - | -11.58 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 109.84 Million | - | -147.05 Million | 47.57 Million | 2.43 Million |
| Other non-cash items | - | 80.48 Million | -179.52 Million | 798.54 Thousand | -58.16 Million | -109.77 Million |
| Investing Cash Flow | -45.33 Million | -140.26 Million | -24.85 Million | -140.5 Million | -135.96 Million | -5.6 Million |
| Investments in PPE | -14.28 Million | -13.42 Million | -13.72 Million | -66.09 Million | -32.86 Million | -11.62 Million |
| Acquisitions | - | 1.07 Million | 102.11 Thousand | 3.15 Million | 896.57 Thousand | 19.98 Thousand |
| Investment purchases | -31.66 Million | -128.69 Million | -41.59 Million | -110.82 Million | -110.18 Million | -196.28 Thousand |
| Sales/Maturities of investments | 617.5 Thousand | 769.37 Thousand | 30.36 Million | 33.26 Million | 6.18 Million | 6.19 Million |
| Other Investing Activities | 1230.00 | -800 Thousand | -10.36 Million | -74.4 Million | -103.1 Million | 0.67 |
| Financing Cash Flow | -19.71 Million | -42.99 Million | 12.72 Million | 98.57 Million | 99.04 Million | -10.18 Million |
| Debt repayment | -20 Million | -2 Million | -13 Million | -100.6 Million | -100.6 Million | -10 Million |
| Dividends payments | -152.2 Thousand | -44.35 Million | -276.91 Thousand | -741.08 Thousand | -270.27 Thousand | -175.38 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 440.93 Thousand | -167.88 Thousand | -276.91 Thousand | -1.29 Million | 99.31 Million | -0.04 |
| Accounts receivables | - | 108.89 Million | - | 88.62 Million | 88.62 Million | -183.64 Million |
| Accounts payables | - | - | - | -183.03 Million | - | - |
| Inventory | - | 3.02 Million | - | -41.05 Million | -41.05 Million | 36.07 Million |
| Other working capital | - | -2.07 Million | - | - | - | 150 Million |
| Cash at beginning of period | 262.54 Million | 444.14 Million | 661.95 Million | 436.22 Million | 511.95 Million | 549.26 Million |
| Cash at end of period | 357.38 Million | 262.54 Million | 444.14 Million | 545.89 Million | 545.89 Million | 511.95 Million |
| Capital Expenditure | -14.28 Million | -13.42 Million | -13.72 Million | -66.09 Million | -32.86 Million | -11.62 Million |
| Effect of forex changes on cash | -531.04 Thousand | 192.95 Thousand | 91.98 Thousand | 459.34 Thousand | -370.32 Thousand | -166.23 Thousand |
| Net cash flow / Change in cash | 94.84 Million | -181.6 Million | -217.8 Million | 109.67 Million | 33.94 Million | -37.3 Million |
| Free Cash Flow | -14.28 Million | -11.19 Million | -103.43 Million | 85.04 Million | 38.37 Million | -182.8 Million |
DYAN
VNT
CHCLY
6332
IDMO
BO